Up to date, expert answers to frequently asked questions (FAQ) about oxygen supply systems, respiratory care and pulse oximetry written by OCC & collaborators.
Who is NOT eligible for oral antiviral treatment?
▪ Asymptomatic patients even if they have a positive COVID-19 test
▪ Symptomatic patients with only negative COVID-19 tests
▪ Patients who do not have risk factors for developing severe or critical COVID-19
▪ Patients who have had symptoms for more than five days
▪ (For NMV/r only) Patients who have severe kidney or liver disease (see clinical guidance materials)
▪ Patients who are allergic to any of the ingredients in the medication
▪ Patients who cannot swallow whole tablets; oral antiviral pills should not be cut or crushed and must be swallowed whole
▪ (For NMV/r only) Patients who are using other drugs that cannot be discontinued or doseadjusted that may result in potentially significant drug-drug interactions with NMV/r.
Patients not eligible for oral antivirals can be reassured that they are receiving person-centered, evidence-based care and be advised on how to treat symptoms safely at home, even if they don’t get a prescription for antivirals.
-By EPiC FHI360